1. Different Weights of the Evidence-Based Medicine Triad in Regulatory, Health Technology Assessment, and Clinical Decision Making

   • Evelyn Schlegl
   • Pierre Ducournau
   • Jörg Ruof

   Current Opinion Open access 11 July 2017 Pages: 213 - 216

2. Integrating Genomics into Drug Discovery and Development: Challenges and Aspirations

   • Rajiv Raja
   • Young S. Lee
   • Koustubh Ranade

   Review Article 08 July 2017 Pages: 217 - 233

   

3. Challenges in Conducting Clinical Trials for Pharmacotherapies in Fragile X Syndrome: Lessons Learned

   • Christina M. Harkins
   • Kelli C. Dominick
   • Craig A. Erickson

   Review Article 27 July 2017 Pages: 235 - 244

4. Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions

   • Mikkel Lindskov Sachs
   • Sofia Kälvemark Sporrong
   • Susanne Kaae

   Original Research Article Open access 18 July 2017 Pages: 245 - 255

   

5. Measuring and Improving Physician Knowledge of Safety Risks Using Traditional and Online Methods in Pharmacovigilance

   • Alexander Liede
   • Justyna Amelio
   • J. Michael Sprafka

   Original Research Article Open access 26 July 2017 Pages: 257 - 266

   

6. Assessing the Value of System Theoretic Process Analysis in a Pharmacovigilance Process: An Example Using Signal Management

   • Ajibade A. Adesina
   • Qasim Hussain
   • Alan M. Hochberg

   Original Research Article 10 July 2017 Pages: 267 - 278

   

7. Forum

   Update 26 June 2017 Pages: 279 - 292

8. Major Pharmaceutical Conferences and Courses

   Update 05 July 2017 Pages: 293 - 296